title: Comment on: A cost-utility analysis of mechanical thrombectomy as an adjunct of intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke: Kim AS, Nguyen-Huynh M, Johnston SC. Stroke 2011;42:2013-2018.
authors.affiliation: Abteilung für Neuroradiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Kollmer
authors.forename: S
authors.initials: S
authors.lastname: Rohde
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002543:Cerebral Hemorrhage / Q000191:economics; D003131:Combined Modality Therapy / Q000191:economics; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D003663:Decision Trees; D004185:Disability Evaluation; D005858:Germany; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007262:Infusions, Intravenous / Q000191:economics; D020767:Intracranial Thrombosis / Q000191:economics* / Q000628:therapy*; D061185:Mechanical Thrombolysis / Q000191:economics*; D019057:Quality-Adjusted Life Years; D015912:Thrombolytic Therapy / Q000191:economics*; D010959:Tissue Plasminogen Activator / Q000191:economics* / Q000627:therapeutic use*
chemical_list: D010959:Tissue Plasminogen Activator